cannapatientcare.com march/april 2022
|
cannabis patient care
11
data focus
PRODUCT TYPE FOR PATIENTS REPORTING NERVE PAIN
CONSUMPTION
6.4%
Bong
5.6%
Other
71.5%
*Included
1.9%
Wax
20.1%
Flower
0.9%
Shatter
3.3%
Other
0.1%
Kief
2%
Resin
0.1%
Hash
CONSUMPTION METHOD FOR PATIENTS
REPORTING MUSCLE PAIN
CONSUMPTION METHOD FOR PATIENTS REPORTING NERVE PAIN
82.6%
Inhaling
15.3%
Orally
2.2%
Tropical
Injury Pain
Patients who selected injur y pain as their primar y symp-
tom equaled 688 sessions. Of those sessions, 33.79 repor ted
using THC, 14.98 repor ted THCA , 7.19 repor ted CBD, 3.06 re-
por ted THCV, 1.7 repor ted CBDA , and 0.15 repor ted CBDV in
their product.
*Included means the patient did not report a specific
product type
SPECIFIC CONSUMPTION METHOD FOR PATIENTS
REPORTING NERVE PAIN
CONSUMPTION
47.7%
*Included
6.8%
Joint
13.8%
Vap Pen
5.8%
Pipe
8.6%
Bong
2.9%
Other
8%
Gummy
2%
Vaporizer
1.7%
Tincture
2.6%
Others
OVERALL RATING FOR PATIENTS REPORTING NERVE PAIN
40.8%
Score of 5
1%
Score of 1
35%
Score of 4
9.9%
Score of 0
10.9%
Score of 3
2.3%
Score of 2
*Included means the patient did not report a specific consumption method
